Mytesi
Total Payments
$1.1M
Transactions
8,565
Doctors
1,910
Companies
1
Payment Trends by Year
| Year | Amount | Transactions | Doctors |
|---|---|---|---|
| 2024 | $188,218 | 1,381 | 561 |
| 2023 | $199,443 | 1,840 | 540 |
| 2022 | $223,620 | 1,142 | 395 |
| 2021 | $105,693 | 1,066 | 349 |
| 2020 | $100,855 | 617 | 199 |
| 2019 | $126,543 | 1,449 | 582 |
| 2018 | $21,214 | 556 | 372 |
| 2017 | $133,869 | 514 | 328 |
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Consulting Fee | $326,577 | 102 | 29.7% |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $264,932 | 1,763 | 24.1% |
| Food and Beverage | $158,808 | 6,496 | 14.4% |
| Honoraria | $131,675 | 80 | 12.0% |
| Unspecified | $115,321 | 20 | 10.5% |
| Compensation for serving as faculty or as a speaker for a medical education program | $62,174 | 22 | 5.7% |
| Travel and Lodging | $39,967 | 82 | 3.6% |
Payments by Type
General
$984,133
8,545 transactions
Research
$115,321
20 transactions
Research Studies & Clinical Trials
| Study Name | Sponsor | Amount | Doctors |
|---|---|---|---|
| One Patient IND | Napo Pharmaceuticals Inc | $83,298 | 0 |
| A Phase 4 Open Label Study to Assess the Safety and Effects of Crofelemer on the Gut Microbiome in Healthy Volunteers and in People Living with HIV/AIDS (PLWHA) with Non-Infectious Diarrhea | Napo Pharmaceuticals Inc | $32,024 | 0 |
Top Doctors Receiving Payments for Mytesi — Page 77
| Doctor | Specialty | Location | Total | Records |
|---|---|---|---|---|
| , MD | Gastroenterology | Dallas, TX | $1.46 | 1 |
| , MD | Gastroenterology | Atlanta, GA | $1.46 | 1 |
| , M.D | Internal Medicine | Winder, GA | $1.40 | 1 |
| , MD | Gastroenterology | Atlanta, GA | $1.21 | 1 |
| , MD | Gastroenterology | Atlanta, GA | $0.94 | 1 |
| , MD | Gastroenterology | Jacksonville, FL | $0.94 | 1 |
| , MD | Gastroenterology | Houston, TX | $0.82 | 1 |
| Fredric Hochman | — | Houston, TX | $0.82 | 1 |
| , MD | Gastroenterology | Houston, TX | $0.82 | 1 |
| , MD | Gastroenterology | Burbank, IL | $0.77 | 1 |
| , MD | Colon & Rectal Surgery | Dallas, TX | $0.64 | 1 |
Ad
Manufacturing Companies
- Napo Pharmaceuticals Inc $1.1M
Product Information
- Type Drug
- Total Payments $1.1M
- Total Doctors 1,910
- Transactions 8,565
About Mytesi
Mytesi is a drug associated with $1.1M in payments to 1,910 healthcare providers, recorded across 8,565 transactions in the CMS Open Payments database. The primary manufacturer is Napo Pharmaceuticals Inc.
Payment data is available from 2017 to 2024. In 2024, $188,218 was paid across 1,381 transactions to 561 doctors.
The most common payment nature for Mytesi is "Consulting Fee" ($326,577, 29.7% of total).
Mytesi is associated with 2 research studies, including "One Patient IND" ($83,298).